Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9202159 | 1.00 | — | — | |
| SCHEMBL384283 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL7573330 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL383877 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL1419297 | 1.00 | — | — | |
| SCHEMBL3327144 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL3327147 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL3940295 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL3326623 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL10320574 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4394019-A1 | LUBRICANT BASE OIL | Idemitsu Kosan Co.,Ltd. (JP) | 2024-07-03 | — | — | EP | disclosed |
| CN-117858934-A | Lubricating base oil | 出光兴产株式会社 | 2024-04-09 | — | — | CN | disclosed |
| CN-117355595-A | Lubricating base oil | 出光兴产株式会社 | 2024-01-05 | — | — | CN | disclosed |
| WO-2023054056-A1 | LUBRICANT BASE OIL | 出光興産株式会社 | 2023-04-06 | — | — | WO | disclosed |
| EP-2868325-B1 | TRANSDERMAL CANCER ANTIGEN PEPTIDE PREPARATION | SUMITOMO DAINIPPON PHARMA CO LTD (JP) | 2017-11-01 | — | — | EP | disclosed |
| US-20160009619-A1 | POLYGLYCERIN DIALKYL OR ALKENYL ETHER, AND COSMETIC COMPOSITION CONTAINING SAME | DAICEL CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-20150150975-A1 | TRANSDERMAL CANCER ANTIGEN PEPTIDE PREPARATION | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2015-06-04 | — | — | US | disclosed |
| EP-2868325-A1 | TRANSDERMAL CANCER ANTIGEN PEPTIDE PREPARATION | Sumitomo Dainippon Pharma Co., Ltd. (JP) | 2015-05-06 | — | — | EP | disclosed |
| EP-2813483-A1 | POLYGLYCERIN DIALKYL OR ALKENYL ETHER, AND COSMETIC COMPOSITION CONTAINING SAME | Daicel Corporation (JP) | 2014-12-17 | — | — | EP | disclosed |
| EP-2710997-A1 | OIL COMPOSITION FOR COSMETICS MATERIAL | Daicel Corporation (JP) | 2014-03-26 | — | — | EP | disclosed |
| EP-1471054-A1 | AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE | Sankyo Company, Limited (JP) | 2004-10-27 | — | — | EP | disclosed |
| US-20040132784-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-07-08 | — | — | US | disclosed |
| WO-2004032900-A1 | AGGREGATE WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN | IDEA AG (DE) | 2004-04-22 | — | — | WO | disclosed |
| US-6723745-B2 | PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE IN WARM BLOODED ANIMAL | SANKYO COMPANY, LIMITED (JP) | 2004-04-20 | — | — | US | disclosed |
| US-20030236297-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2003-12-25 | — | — | US | disclosed |
| EP-0938842-B1 | Sustained release pheromone dispenser | SHINETSU CHEMICAL CO (JP) | 2003-10-15 | — | — | EP | disclosed |
| EP-1300405-A1 | AMINO ALCOHOL DERIVATIVES | Sankyo Company, Limited (JP) | 2003-04-09 | — | — | EP | disclosed |
| US-6355236-B2 | Sustained release pheromone formation | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-03-12 | — | — | US | disclosed |
| US-20010053372-A1 | SUSTAINED RELEASE PHEROMONE FORMATION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-12-20 | — | — | US | disclosed |
| EP-0938842-A1 | Sustained release pheromone dispenser | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1999-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236297-A1 | Amino alcohol derivatives | CD4, ADH1C, ADH1A | TSHR 1187/4885THRB 935/4885FAAH 1462/4885 |
| US-20040132784-A1 | Amino alcohol derivatives | CD4, ADH1C, ADH1A | TSHR 1187/4885THRB 935/4885FAAH 1462/4885 |
| US-20160009619-A1 | POLYGLYCERIN DIALKYL OR ALKENYL ETHER, AND COSMETIC COMPOSITION CONTAINING SAME | DEGS1, DAGLA, MGLL | TSHR 3015/4885THRB 3495/4885FAAH 407/4885 |
| US-20150150975-A1 | TRANSDERMAL CANCER ANTIGEN PEPTIDE PREPARATION | TAP1, TAP2, MICA | TSHR 1876/4885THRB 2727/4885FAAH 3738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.